🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn about treatment for a type of b...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT06012929
Treatments Being Tested
This is an intermediate-size expanded access protocol to provide ONC201 (do...
Status
Approved For Marketing
Location
BMDACC at Banner University Medical Center Phoenix
Start Date
TBD
Trial ID
NCT04617002
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, int...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2023-01-23
Trial ID
NCT05580562
Treatments Being Tested
This was a Phase 2, Simon two-stage, non-randomized, open-label, 2-arm tria...
Status
Terminated
Location
Rutgers, The State University of New Jersey
Start Date
2018-03-21
Trial ID
NCT03485729
Treatments Being Tested
The purpose of this phase I trial is to test the safety and cancer preventi...
Status
Recruiting
Location
University of Michigan Rogel Cancer Center
Start Date
2025-10-06
Trial ID
NCT05630794
This was a Phase 2, open-label, 2-arm study of dordaviprone (ONC201) in pat...
Status
Terminated
Location
University of California, San Francisco
Start Date
2017-10-30
Trial ID
NCT03295396
Treatments Being Tested
The BIOMEDE 2.0 study is the second stage of the BIOMEDE multi-arm, multist...
Status
Recruiting
Location
Aarhus Universitetshospital Skejby
Start Date
2022-09-29
Trial ID
NCT05476939
Treatments Being Tested
This is a single-center Phase 1 trial of 20 patients with AML/MDS. Eligible...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2019-07-30
Trial ID
NCT03932643
Treatments Being Tested
This was a Phase 2, open-label, 6-arm, multi-center study of dordaviprone (...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2016-01
Trial ID
NCT02525692
Treatments Being Tested
This was a Phase 1, open label, multicenter, 8-arm, dose escalation study o...
Status
Terminated
Location
UCSF, Benioff Children's Hospital
Start Date
2018-01-25
Trial ID
NCT03416530
Treatments Being Tested